Brighid Biologicals Private Limited

Brighid Biologicals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U51909TG2019PTC136920 Incorporated 18 November 2019 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹72.04 Lakh
▲ 12% YoY
Net profit · FY 2024
₹55,453
Net margin 0.8%
EBITDA · FY 2024
₹75,559
EBITDA margin 1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Brighid Biologicals Private Limited

Data last updated:

Brighid Biologicals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC136920. Its GSTIN is 36AAICB7549J1Z7 (Telangana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sribhavya Gupta Kanduri and Naresh Kumar Peddi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No8 – 27 Plot 12&16 New Sainagar Colony Road – 2 Peerzadiguda Uppal, Hyderabad, Telangana, India – 500039.

As per the financials filed for FY 2024, the company reported a revenue of ₹72.04 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹55,453 (net margin 0.8%) and EBITDA of ₹75,559 (EBITDA margin 1%).

Brighid Biologicals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0050933).

Company details

CIN U51909TG2019PTC136920
Registration Number 136920
Incorporation Date 18 November 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0050933

Recognitions & Rankings of Brighid Biologicals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-20-0050933

Contact details

Brighid Biologicals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No8 – 27 Plot 12&16 New Sainagar Colony Road – 2 Peerzadiguda Uppal, Hyderabad, Telangana, India – 500039
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Brighid Biologicals Private Limited, buy the company report.

Comprehensive company report
Brighid Biologicals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Brighid Biologicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Brighid Biologicals Private Limited, buy the company report.

Financials of Brighid Biologicals Private Limited

FY 2025 filings available

Brighid Biologicals Private Limited reported revenue of ₹72.04 Lakh (up 12% YoY) for FY 2024.

Revenue · FY 2024
₹72.04 Lakh ▲ 12%
Net profit · FY 2024
₹55,453 margin 0.8%
EBITDA · FY 2024
₹75,559 margin 1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 12%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 40%

Revenue rose 12% in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹75,559
Profit Before Tax
Tax Expense
Net Profit (PAT)₹55,453
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Brighid Biologicals Private Limited, buy the company report.

Board of directors of Brighid Biologicals Private Limited

Brighid Biologicals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sribhavya Gupta KanduriDirector18 Nov 20196 Years 11 MonthsCurrent
Naresh Kumar PeddiDirector18 Nov 20196 Years 11 MonthsCurrent

Peer comparison

Brighid Biologicals Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Astranova Biotech Private Limited₹72.32 Lakh (FY 2025)-25.0%Pune, Maharashtra, India
Ipl Agro Private Limited₹72.23 Lakh (FY 2018)249.0%Gohana, Haryana, India
Magnovia Pharmaceutical Private Limited₹72.17 Lakh (FY 2019)175.0%Navi Mumbai, Maharashtra, India
Ayurudnik Remedies Private Limited₹72.12 Lakh (FY 2025)93.0%Omerga, Maharashtra, India
AAA Salt and Chemicals Private Limited₹72.11 Lakh (FY 2025)-81.0%Vadodara, Gujarat, India
Brighid Biologicals Private Limitedthis company₹72.04 Lakh (FY 2024)₹55,4530.8%12.0%Hyderabad, Telangana, India
Voluenta Pharmaceuticals Private Limited₹72.03 Lakh (FY 2025)-22.0%New Delhi, Delhi, India
Sherwin Lifescience Private Limited₹72.03 Lakh (FY 2025)2134.0%Thane, Maharashtra, India
Vikram Paints Private Limited₹72 Lakh (FY 2024)-33.0%Uttar Pradesh, India
Thrive Therapeutic Private Limited₹71.9 Lakh (FY 2025)-82.0%Thane, Maharashtra, India

To see the full peer comparison of Brighid Biologicals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Brighid Biologicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Brighid Biologicals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAICB7549J1Z7TelanganaActive23 Jan 2020

To see the full GST registrations and return filing status of Brighid Biologicals Private Limited, buy the company report.

Recent activity

Brighid Biologicals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Naresh Kumar Peddi was appointed as Director on 18 Nov 2019.

AGM
Brighid Biologicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Brighid Biologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Naresh Kumar Peddi was appointed as Director.
Appointed
Sribhavya Gupta Kanduri was appointed as Director.
Incorporation
18 Nov 2019
Brighid Biologicals Private Limited was registered on 18 Nov 2019 with Roc Hyderabad & aged 6 years 11 months as per MCA records.

Frequently asked questions

Brighid Biologicals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2019 (7+ years old) and is registered under CIN U51909TG2019PTC136920.

Brighid Biologicals has 2 current directors:

The latest financial statements of Brighid Biologicals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Brighid Biologicals is 36AAICB7549J1Z7, registered in Telangana.

The CIN (Corporate Identification Number) of Brighid Biologicals is U51909TG2019PTC136920. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Brighid Biologicals was incorporated on 18 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Brighid Biologicals by revenue are Astranova Biotech Private Limited, Ipl Agro Private Limited, Magnovia Pharmaceutical Private Limited, Ayurudnik Remedies Private Limited, AAA Salt and Chemicals Private Limited and 4 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Naresh Kumar Peddi was appointed as Director on 18 Nov 2019. Sribhavya Gupta Kanduri was appointed as Director on 18 Nov 2019.

Yes, Brighid Biologicals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0050933).

The registered office of Brighid Biologicals is at H.No8 – 27 Plot 12&16 New Sainagar Colony Road – 2 Peerzadiguda Uppal, Hyderabad, Telangana, India – 500039.

Brighid Biologicals operates in the pharma industry, in the drug formulation and development segment.